Top news of the week: 02.09.2021.
Career And Jobs
Feng Zhang's lab develops potential breakthrough in RNA editing delivery using 'ultracompact' versions of Cas13
As one of the pioneers behind CRISPR, the Broad Institute's Feng Zhang has fashioned himself into a gene editing Renaissance man in recent years with a finger in every pie. For RNA editing, ...
From bench to boardroom: 20 of the most influential biopharma R&D executives in drug development
Biopharma is no stranger to major scientific innovations, but when you talk to the movers and shakers in the field on who has influenced their work the most, you start to hear a few key ...
Novel “scArches” Algorithm Maps Single-Cell Data to Reference Atlases
A novel deep learning strategy, single-cell architectural surgery (scArches), compares new datasets from single-cell genomics with existing references.
Self-Injecting Pill Could Allow Oral Delivery of Monoclonal Antibody and Other Protein Drugs
In preclinical tests, traditionally injected drugs, including a monoclonal antibody, insulin, and epinephrine, could be delivered orally with comparable results.
Biotech Company Driven by Cutting Edge Science and Patients, Not Ego
On June 26, Intellia announced the first-ever clinical data supporting the safety and efficacy of in vivo CRISPR genome editing in human patients.
Umoja’s New Manufacturing Facility Highlights Colorado's Biopharma Potential
The state-of-the-art 146,000 square foot facility will make it easier for Umoja to eliminate crucial CAR-T production barriers.
Under withering fire, Galapagos founder and CEO Onno van de Stolpe is exiting top post
Twenty-two years after Dutch businessman Onno van de Stolpe founded Galapagos and oversaw its rise, and fall, the beleaguered biotech CEO is calling it quits. The biotech reported just ...
TeselaGen Biotechnology Teams Up with iGEM to Advance Synthetic Biology in Developing Countries
TeselaGen Biotechnology announced today that it has partnered with the iGEM Foundation to support the iGEM Design League, a new competition that aims to advance synthetic biology, starting ...